Alternative Dosing Strategy of Ruxolitinib in Patients With Myelofibrosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William V Williams, MD
Incyte Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Highland, California, United States
- Facility name not stated
La Jolla, California, United States
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
Jacksonville, Florida, United States
- Facility name not stated
Orange City, Florida, United States
- Facility name not stated
Winter Park, Florida, United States
- Facility name not stated
Atlanta, Georgia, United States
- Facility name not stated
Augusta, Georgia, United States
- Facility name not stated
Iowa City, Iowa, United States
- Facility name not stated
Baltimore, Maryland, United States
- Facility name not stated
Ann Arbor, Michigan, United States
- Facility name not stated
Southfield, Michigan, United States
- Facility name not stated
Morristown, New Jersey, United States
- Facility name not stated
Armonk, New York, United States
- Facility name not stated
Hickory, North Carolina, United States
- Facility name not stated
Canton, Ohio, United States
- Facility name not stated
Hazleton, Pennsylvania, United States
- Facility name not stated
Hershey, Pennsylvania, United States
- Facility name not stated
Charleston, South Carolina, United States
- Facility name not stated
Sioux Falls, South Dakota, United States
- Facility name not stated
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2011
- Primary completion
- 31 Mar 2013
- Completion
- 30 Apr 2013
- Last update posted
- 27 Mar 2019
- Registered enrollment
- 45
- Registry id
- NCT01445769
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.